Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis [NCT00317629]

BACKGROUND: Cutaneous Leishmaniasis is a worldwide disease, endemic in 88 countries, that has shown an increasing incidence over the last two decades. So far, pentavalent antimony compounds have been considered the treatment of choice, with a percentage of cure of about 85%. However, the high effica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Silva, Sandra Y, Rueda, Ligia C, López, Marcos, Vélez, Iván D, Rueda-Clausen, Christian F, Smith, Daniel J, Muñoz, Gerardo, Mosquera, Hernando, Silva, Federico A, Buitrago, Adriana, Díaz, Holger, López-Jaramillo, Patricio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2006
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1524981/
https://ncbi.nlm.nih.gov/pubmed/16700912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-7-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados